Literature DB >> 24533268

Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment.

Mike Y Osei-Atweneboana1, Daniel A Boakye2, Kwablah Awadzi3, John O Gyapong4, Roger K Prichard5.   

Abstract

Ivermectin (IVM) has been in operational use for the control of onchocerciasis for two decades and remains the only drug of choice. To investigate the parasitological responses and genetic profile of Onchocerca volvulus, we carried out a 21 month epidemiological study to determine the response of the parasite to IVM in 10 Ghanaian endemic communities. Onchocerca nodules were surgically removed from patients in three IVM response categories (good, intermediate and poor) and one IVM naïve community. DNA from adult worms was analyzed to determine any association between genotype and IVM response phenotypic. Embryogramme analysis showed significantly higher reproductive activity in worms from poor response communities, which had up to 41% of females with live stretched microfilaria (mf) in utero, despite IVM treatment, compared with good response communities, which had no intra-uterine stretched mf. β-tubulin isotype 1 gene has been shown to be linked to IVM selection in O. volvulus and also known to be associated with IVM resistance in veterinary nematodes. We have genotyped the full length genomic DNA sequence of the β-tubulin gene from 127 adult worms obtained from the four community categories. We found SNPs at 24 sites over the entire 3696 bp. Eight of the SNPs occurred at significantly higher (p < 0.05) frequencies in the poor response communities compared with the good response communities and the IVM naïve community. Phenotypic and genotypic analyses show that IVM resistance has been selected and the genotype (1183GG/1188CC/1308TT/1545GG) was strongly associated with the resistance phenotype. Since the region in the β-tubulin gene where these four SNPs occur is within 362 bp, it is feasible to develop a genetic marker for the early detection of IVM resistance.

Entities:  

Keywords:  Anthelmintic resistance; Genetic changes; Ivermectin; Onchocerca volvulus

Year:  2012        PMID: 24533268      PMCID: PMC3862422          DOI: 10.1016/j.ijpddr.2012.01.005

Source DB:  PubMed          Journal:  Int J Parasitol Drugs Drug Resist        ISSN: 2211-3207            Impact factor:   4.077


  35 in total

1.  Selection at a gamma-aminobutyric acid receptor gene in Haemonchus contortus resistant to avermectins/milbemycins.

Authors:  William J Blackhall; Roger K Prichard; Robin N Beech
Journal:  Mol Biochem Parasitol       Date:  2003-10       Impact factor: 1.759

2.  Ivermectin resistance.

Authors:  W L Shoop
Journal:  Parasitol Today       Date:  1993-05

3.  The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.

Authors:  W R Brieger; A K Awedoba; C I Eneanya; M Hagan; K F Ogbuagu; D O Okello; O O Ososanya; E B Ovuga; M Noma; O O Kale; G M Burnham; J H Remme
Journal:  Trop Med Int Health       Date:  1998-12       Impact factor: 2.622

4.  Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin.

Authors:  S L Kläger; J A Whitworth; M D Downham
Journal:  Trop Med Int Health       Date:  1996-10       Impact factor: 2.622

5.  Cloning and characterization of cDNAs encoding beta-tubulin from Dirofilaria immitis and Onchocerca volvulus.

Authors:  T G Geary; S C Nulf; S J Alexander-Bowman; B M Mahmoud; R K Prichard; R D Klein
Journal:  J Parasitol       Date:  1998-04       Impact factor: 1.276

Review 6.  The problem of anthelmintic resistance in nematodes.

Authors:  R K Prichard; C A Hall; J D Kelly; I C Martin; A D Donald
Journal:  Aust Vet J       Date:  1980-05       Impact factor: 1.281

7.  A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients.

Authors:  J K L Eng; R K Prichard
Journal:  Mol Biochem Parasitol       Date:  2005-08       Impact factor: 1.759

8.  An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.

Authors:  K Awadzi; D A Boakye; G Edwards; N O Opoku; S K Attah; M Y Osei-Atweneboana; J K Lazdins-Helds; A E Ardrey; E T Addy; B T Quartey; K Ahmed; B A Boatin; E W Soumbey-Alley
Journal:  Ann Trop Med Parasitol       Date:  2004-04

9.  Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.

Authors:  K Awadzi; S K Attah; E T Addy; N O Opoku; B T Quartey; J K Lazdins-Helds; K Ahmed; B A Boatin; D A Boakye; G Edwards
Journal:  Ann Trop Med Parasitol       Date:  2004-06

10.  The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.

Authors:  K Awadzi; K Y Dadzie; S Kläger; H M Gilles
Journal:  Trop Med Parasitol       Date:  1989-09
View more
  15 in total

1.  Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.

Authors:  Samuel Wanji; Jonas A Kengne-Ouafo; Mathias E Esum; Patrick W N Chounna; Nicholas Tendongfor; Bridget F Adzemye; Joan E E Eyong; Isaac Jato; Fabrice R Datchoua-Poutcheu; Elvis Kah; Peter Enyong; David W Taylor
Journal:  Parasit Vectors       Date:  2015-04-02       Impact factor: 3.876

2.  Bioinformatics in Africa: The Rise of Ghana?

Authors:  Thomas K Karikari
Journal:  PLoS Comput Biol       Date:  2015-09-17       Impact factor: 4.475

3.  A simple isothermal DNA amplification method to screen black flies for Onchocerca volvulus infection.

Authors:  Andy Alhassan; Benjamin L Makepeace; Elwyn James LaCourse; Mike Y Osei-Atweneboana; Clotilde K S Carlow
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

4.  Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.

Authors:  Luc E Coffeng; Wilma A Stolk; Achim Hoerauf; Dik Habbema; Roel Bakker; Adrian D Hopkins; Sake J de Vlas
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

5.  Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.

Authors:  Stephen R Doyle; Catherine Bourguinat; Hugues C Nana-Djeunga; Jonas A Kengne-Ouafo; Sébastien D S Pion; Jean Bopda; Joseph Kamgno; Samuel Wanji; Hua Che; Annette C Kuesel; Martin Walker; Maria-Gloria Basáñez; Daniel A Boakye; Mike Y Osei-Atweneboana; Michel Boussinesq; Roger K Prichard; Warwick N Grant
Journal:  PLoS Negl Trop Dis       Date:  2017-07-26

6.  Colorimetric tests for diagnosis of filarial infection and vector surveillance using non-instrumented nucleic acid loop-mediated isothermal amplification (NINA-LAMP).

Authors:  Catherine B Poole; Zhiru Li; Andy Alhassan; Dylan Guelig; Steven Diesburg; Nathan A Tanner; Yinhua Zhang; Thomas C Evans; Paul LaBarre; Samuel Wanji; Robert A Burton; Clotilde K S Carlow
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

7.  Single-Nucleotide Polymorphism Associates' β-Tubulin Isotype-1 Gene in Onchocerca volvulus Populations in Ivermectin-Treated Communities in Taraba State, Nigeria.

Authors:  Danlami E Akafyi; Iliya S Ndams; Ishaya H Nock; Gloria Chechet; Alfons Renz
Journal:  Acta Parasitol       Date:  2021-07-19       Impact factor: 1.440

8.  Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

Authors:  Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

9.  Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?

Authors:  Kwadwo K Frempong; Martin Walker; Robert A Cheke; Edward Jenner Tetevi; Ernest Tawiah Gyan; Ebenezer O Owusu; Michael D Wilson; Daniel A Boakye; Mark J Taylor; Nana-Kwadwo Biritwum; Mike Osei-Atweneboana; María-Gloria Basáñez
Journal:  Clin Infect Dis       Date:  2016-03-21       Impact factor: 9.079

10.  Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.

Authors:  Ghaith Aljayyoussi; Hayley E Tyrer; Louise Ford; Hanna Sjoberg; Nicolas Pionnier; David Waterhouse; Jill Davies; Joanne Gamble; Haelly Metuge; Darren A N Cook; Andrew Steven; Raman Sharma; Ana F Guimaraes; Rachel H Clare; Andrew Cassidy; Kelly L Johnston; Laura Myhill; Laura Hayward; Samuel Wanji; Joseph D Turner; Mark J Taylor; Stephen A Ward
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.